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Abstract
Background: Diarrhoeagenic Escherichia coli (DEC) infections are common in children in low-middle income
countries (LMICs). However, detecting the various DEC pathotypes is complex as they cannot be differentiated by
classical microbiology. We developed four multiplex real-time PCR assays were to detect virulence markers of six
DEC pathotypes; specificity was tested using DEC controls and other enteric pathogens. PCR amplicons from the six
E. coli pathotypes were purified and amplified to be used to optimize PCR reactions and to calculate reproducibility.
After validation, these assays were applied to clinical samples from healthy and diarrhoeal Vietnamese children and
associated with clinical data.
Results: The multiplex real-time PCRs were found to be reproducible, and specific. At least one DEC variant was
detected in 34.7% (978/2815) of the faecal samples from diarrhoeal children; EAEC, EIEC and atypical EPEC were
most frequent Notably, 41.2% (205/498) of samples from non-diarrhoeal children was positive with a DEC
pathotype. In this population, only EIEC, which was detected in 34.3% (99/289) of diarrhoeal samples vs. 0.8% (4/
498) non-diarrhoeal samples (p < 0.001), was significantly associated with diarrhoea. Multiplex real-time PCR when
applied to clinical samples is an efficient and high-throughput approach to DEC pathotypes.
Conclusions: This approach revealed high carriage rates of DEC pathotypes among Vietnamese children. We
describe a novel diagnostic approach for DEC, which provides baseline data for future surveillance studies assessing
DEC burden in LMICs.
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Background
Diarrhoeal illness remains the second-highest cause of
mortality and morbidity worldwide [1–3]; the main bur-
den of this disease occurs in children in South Asia,
Southeast Asia, and Africa [3]. Among the bacterial
pathogens associated with diarrhoea in children, Escheri-
chia coli are repeatedly the most common food borne
pathogenic species identified [3–6]. However, identifying
diarrhoea-causing E. coli can be complex, as pathogenic
variants cannot be delineated from commensal E. coli
solely by microbiological culture.
Diarrhoeagenic E. coli (DEC) can generally be divided
into six pathotypes (enterotoxigenic E. coli, ETEC; enter-
oaggregative E. coli, EAEC; enteropathogenic E. coli,
EPEC, enteroinvasive E. coli, EIEC; enterohemorrhagic
E. coli, EHEC and shiga-toxin producing E. coli, STEC),
based on specific virulence markers that are encoded on
plasmids and/or chromosomal islands [7]. ETEC, EAEC,
and EPEC have all been implicated in causing diarrhoea
in young children in low-middle income countries
(LMICs) [8–10].
For ETEC, heat-stable toxin producing strains (ST-
ETEC) are among the most important pathogens associ-
ated with diarrhoea in children [9–11]. Similarly, typical
EPEC (possessing both eae and bfp virulence genes) are
more strongly associated with diarrhoea in children in
developing regions than atypical EPEC strains which lack
bfp [6, 12]. EIEC are virtually indistinguishable from Shi-
gella spp., which are essentially an independent genus
within the broader E. coli population. STEC are com-
monly associated with food-borne disease outbreaks in
developed countries and have higher mortality than
other E. coli pathotypes due to sequelae of haemolytic
uraemic syndrome (HUS) [13–15]. The epidemiology of
STEC in LMICs, particularly in children in Southeast
Asia, are not well described.
The proportion of diarrhoeal disease associated with
DEC in Vietnam is not well investigated as measuring
the prevalence of these pathogens in diarrhoeal cases
and non-diarrhoeal controls is laborious and not rou-
tinely performed. Of the limited DEC studies conducted
in Vietnam an investigation originating in Hanoi de-
tected DEC in 22% of stool sample from diarrhoeal cases
and 12% of controls using conventional multiplex PCR
[16]. Here, we aimed to develop a set of standardized
multiplex real-time PCR assays to identify the various
DEC in complex samples in a comparatively short turn-
around time. To establish the multiplex real-time PCR
assays to identify the six DEC pathotypes we designed
new or adapted existing specific primers and probes for
nine DEC associated genes. The real-time PCR assays
were optimized and then used to determine the preva-
lence of DEC in children with and without diarrhoea
disease in Ho Chi Minh City (HCMC), Vietnam. Lastly,
we combined these PCR data with available clinical data
to identify clinical features in children infected with dif-
fering DEC pathotypes and to determine the potential
effect of DEC in the stools of diseased and non-diseased
children.
Results
Multiplex real-time PCR assay for detecting
diarrhoeagenic Escherichia coli
We firstly validated PCR amplification for ETEC, EAEC,
EIEC/Shigella, EPEC, and STEC in monoplex using
cloned target sequences and then with genomic DNA
extracted from the various E. coli pathovars. The sensi-
tivity of the primer and probe sets was determined by
generating a series of standard curves using 10-fold dilu-
tions of control plasmid DNA. The limit of detection for
all targets, including the uidA control, was five copies
per reaction, with the exception of aggR which could be
detected down to 50 copies per reaction. Each primer
and probe set were tested against a panel of commonly
isolated pathogens found in stool samples, which in-
cluded Staphylococcus aureus, Klebsiella pneumoniae,
Salmonella spp., Campylobacter coli, Campylobacter
jejuni, Shigella sonnei, Shigella flexneri, Enterobacter,
Proteus, norovirus, and rotavirus (these viruses were se-
lected as they are most commonly found viruses in the
stools of children with diarrhoea). No amplification was
observed in any sample other than those containing E.
coli.
Ultimately, the PCR assays were multiplexed into four
reactions, and the sensitivity, intra-assay and inter-assay
CVs across the nine target sequences were calculated for
each multiplexed PCR reaction. The Ct values for each
target were equivalent between the monoplex and multi-
plex reactions, confirming that multiplexing did not
impact sensitivity. The intra-assay and inter-assay CVs
ranged from 0.01 to 1.54% and from 0.01 to 2.12%,
respectively (Table 1). The linear regressions of the
standard curves were between 0.992–0.999 for all targets
tested. The resulting efficiency of the amplification
ranged from 90.9 to 105.7%, demonstrating the multi-
plex real-time PCR assays were well optimized, reprodu-
cible, and specific.
The prevalence of diarrhoeagenic Escherichia coli from
faecal specimens of children hospitalized with diarrhoea
Between May 2014 and April 2016, we amassed 2815
MC sweeps (i.e. faecal samples plated on MC media)
from 3166 children hospitalized with bloody and/or mu-
coid diarrhoea at three tertiary hospitals in HCMC. A
single faecal sample was collected from each child within
their first 2 days of hospital admission for diarrhoea.
The majority of patients were male (1731/2815; 61.5%),
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with ages ranging from one month to 15 years (median
age 10months, IQR 6.6–17.1 months).
We employed the four multiplex real-time DEC PCRs
on all 2815 MC sweeps to identify DEC targets poten-
tially associated with clinical infection. At least one PCR
amplification associated with a DEC variant was positive
in 34.7% (978/2815) of the MC sweeps from paediatric
patients hospitalized with diarrhoea. Among the DEC
amplification positive samples, EAEC was the most com-
mon variant detected, with aggR amplified in 15.7%
(443/2815) of samples (Table 2). Other commonly amp-
lified DEC targets included EIEC/Shigella and EPEC,
which were identified in 12.4% (349/2815) and 12.2%
(343/2815) of the MC sweep samples, respectively.
Within the EPEC pathotype, atypical EPEC positive
samples (eae positive, bfpA negative) were more preva-
lent than typical EPEC positive samples (eae positive,
bfpA positive); 93.9% (322/343) vs. 6.1% (21/343), re-
spectively. ETEC was detected in 6% (182/2815) of sam-
ples, with only a limited number of these samples (8.2%;
15/182) producing an amplicon for heat stable toxin
(estA). Four diarrhoeal patients harboured samples con-
taining the Shiga toxin-producing genes (stx1/stx2).
Among the four cases associated with an STEC positive
sample, one was positive for eae and one was positive
Table 1 Reproducibility of the assays on diluted plasmid DNA containing cloned target sequences
Target
sequence
Co-efficient of
variance (%)
Target concentration
5 × 107 5 × 106 5 × 105 5 × 104 5 × 103 5 × 102 5 × 101 5 × 100
uidA Intra-assay variation a 0.13 0.09 0.14 0.26 0.34 0.12 0.82 0.52
Inter-assay variation b 0.18 0.18 0.21 0.73 0.66 0.74 0.66 0.93
eltB Intra-assay variation 0.03 0.04 0.06 0.10 0.35 0.16 0.27 0.35
Inter-assay variation 0.07 0.11 0.05 0.23 0.41 0.50 0.38 0.67
estA Intra-assay variation 0.01 0.05 0.03 0.25 0.19 0.16 0.15 0.06
Inter-assay variation 0.15 0.03 0.04 0.05 0.52 0.36 0.12 0.76
aggR Intra-assay variation 0.11 0.08 0.08 0.15 0.20 0.37 0.29 –
Inter-assay variation 0.06 0.11 0.33 0.03 0.29 0.23 1.05 –
ipaH Intra-assay variation 0.19 0.17 0.20 0.12 0.12 0.60 0.15 0.11
Inter-assay variation 0.23 0.28 0.20 0.07 0.42 0.20 0.52 1.42
eae Intra-assay variation 0.07 0.24 0.29 0.06 0.26 0.76 0.20 0.48
Inter-assay variation 0.38 0.16 0.06 0.46 0.82 0.64 0.63 0.88
bfpA Intra-assay variation 0.03 0.09 0.11 0.17 0.50 0.90 0.63 0.90
Inter-assay variation 0.01 0.11 0.05 0.06 0.18 0.38 0.75 1.23
rfbE Intra-assay variation 0.03 0.11 0.09 0.42 0.20 0.70 0.98 0.30
Inter-assay variation 0.02 0.04 0.10 0.23 0.60 1.49 1.29 1.08
stx1 Intra-assay variation 0.13 0.13 0.17 0.21 0.50 0.74 0.97 0.60
Inter-assay variation 0.22 0.50 0.71 0.98 1.19 1.57 1.95 0.55
stx2 Intra-assay variation 0.11 0.14 0.18 0.17 0.25 1.54 0.81 0.24
Inter-assay variation 0.12 0.22 0.43 0.47 0.87 1.54 2.12 1.97
a Intra-assay variation was calculated by measuring the co-efficient of variance of the Ct value on three concurrently run assays
b Inter-assay variation was calculated by comparing variation in Ct value on three independently run assays
Table 2 DEC detected in children hospitalized with diarrhoea
(N = 2815)
Pathotypes Target gene N %
ETEC 182 6.5
LT-ETEC elt 167 5.9
ST-ETEC est 7 0.2
LT-ST-ETEC elt & est 8 0.3
EAEC aggR 443 15.7
EIEC/Shigella ipaH 349 12.4
EPEC 343 12.2
Atypical EPEC eae 322 11.4
Typical EPEC eae & bfpA 21 0.7
EHEC/STEC 46 1.6
O157 eae & rfbE_O157 20 0.7
non-eae O157 rfbE_O157 26 0.9
stx1/stx2 4 0.1
Negative 1837 65.3
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for both eae and rfbE_O157. Of the two STEC cases that
were amplification positive for eae and rfbE_O157, one
was additionally positive for eltB (ETEC), the other was
positive for aggR (EAEC).
Clinical manifestations of diarrhoeagenic Escherichia coli
mono-infection
To investigate clinical syndromes associated with the
various DEC in Vietnam, clinical data associated with
the patients were accessed and compared between
pathotype groups (Table S2). Patient samples from
which multiple DEC pathogens were amplified were ex-
cluded. Notably, ~ 70% of those with an ETEC, EAEC,
EPEC, or STEC O157 positive sample were associated
with mucoid, non-bloody diarrhoea, whereas EIEC/Shi-
gella was significantly associated with visible bloody
diarrhoea (39.7%, 46/116, p < 0.001, χ2 test). EAEC was
the most commonly identified DEC in mono-infection.
This pathotype was more commonly associated with
children that had wasting or severe wasting (13.5%, 23/
170; p = 0.013, Fisher’s exact test) than the other DEC
variants. Whilst EHEC_O157 was identified less fre-
quently than other pathotypes, it was significantly associ-
ated with moderate and severe dehydration (40%, 8/20;
p = 0.010, Fisher’s exact test), which commonly required
intravenous rehydration therapy.
Generally, we found that infections associated with
DEC positive samples were uncomplicated; > 90% of pa-
tients had improved or recovered after 3 days and their
median hospital stay was 5 days [IQR 3–7 days]. The use
of antimicrobials within this study population was high,
with 81.3% (1513/1861) of patients receiving empirical
antimicrobial treatment prior to any diagnostic testing,
which may impact on the detection of various DEC, de-
pending on their susceptibility profile. Fluoroquinolones,
specifically ciprofloxacin, were the most commonly used
class of antimicrobials in those with a DEC in their stool
(957/1512, 63.3%).
Diarrhoeagenic Escherichia coli from faecal specimens of
diarrhoeal hospitalized children vs. healthy non-
diarrhoeal children
Between March 2016 and August 2016, 498 MC sweeps
were additionally collected from faecal samples taken
from healthy children residing in HCMC and participat-
ing in a cohort study [17]. The majority of healthy chil-
dren were male (269/498; 54.0%), with their age when
sampled ranging from 24months to 5 years (median age
46.4 months, IQR 35.6–52.5 months). In a comparable
manner to the diarrhoeal samples, we screened the MC
extractions from these healthy children with the multi-
plex real-time PCRs to detect DEC. At least one patho-
type of DEC was detected in 41.2% (205/498) of samples
associated with non-diarrhoeal children (Table 3).
To determine the prevalence and distribution of the
various DEC in healthy and diarrhoeal children, we com-
pared the data from the healthy children with a subset
of the data from matched children in the diarrhoeal
study which were between the ages of 2 and 5 years old
(319 children; median age 31.5 months, IQR 26.7–38.9
months). The prevalence of ETEC, EAEC, and EHEC_
O157 in faecal samples was not significantly different be-
tween children with or without diarrhoea (Table 3,
Fig. 2). Furthermore, EPEC was detected significantly
Table 3 Direct comparison of DEC detected in samples from children hospitalized with diarrhoea and healthy children
Diarrhoeagenic E. coli Target gene Diarrhoea N (%) Non-diarrhoea N (%) p value*
Number 319 498
ETEC 29 (9.1) 42 (8.4) 0.745
LT-ETEC elt 25 (7.8) 39 (7.8) 0.998
ST-ETEC est 1 (0.3) 3 (0.6) 1.000
LT-ST-ETEC elt & est 3 (0.9) 0 (0.0) 0.059
EAEC aggR 50 (15.7) 89 (17.9) 0.415
EIEC/Shigella ipaH 93 (29.2) 4 (0.8) < 0.001
EPEC 39 (12.2) 93 (18.7) 0.015
Atypical EPEC eae 38 (11.9) 90 (18.1) 0.018
Typical EPEC eae & bfpA 1 (0.3) 3 (0.6) 1.000
EHEC/STEC 13 (4.1) 20 (4.0) 0.712
O157 eae & rfbE_O157 5 (1.6) 5 (0.6) 0.524
non-eae O157 rfbE_O157 8 (2.5) 18 (3.4) 0.379
stx1/stx2 0 – 7 (1.4) 0.033
Negative 163 (51.1) 293 (58.8) 0.030
*p value from χ2 test or Fisher’s exact test
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more frequently in the non-diarrhoeal samples (18.7%,
93/498) than the diarrhoeal samples (11.4%, 33/289)
(p = 0.019, χ2 test) (Table 3). The only DEC that was sig-
nificantly associated with the diarrhoeal samples was
EIEC/Shigella, which was detected in 34.3% (99/289) of
diarrhoeal samples vs. 0.8% (4/498) non-diarrhoeal sam-
ples (p < 0.001, Fisher’s exact test).
The distribution of DEC co-infection among the cases
and the controls was complex and highly variable (Fig. 2).
The most common co-infections in the diarrhoeal group
were EAEC + EIEC/Shigella (3.8%, 12/319) and EAEC +
EIEC/Shigella + ETEC (2.2%, 7/319); whereas EPEC +
EAEC (3.4%, 17/498) was more common in the healthy
control group. Co-infection with more than one DEC was
more likely to be associated with diarrhoeal disease than
with healthy controls (16.3%, 52/319 vs. 9.6%, 48/498, p =
0.005, χ2 test). However, due to the predominant presence
of EIEC/Shigella in the diarrhoeal group, EIEC/Shigella in-
fection was a potential confounder.
To disaggregate the potential confounding effect of
EIEC/Shigella, we performed binary univariate and
multivariate logistic regression to identify variables and
DEC that were associated with diarrhoeal disease in chil-
dren aged 24–60 months (Table 4). In the univariate
model, co-infection with ETEC, mono-infection with
EIEC/Shigella, co-infection with EIEC/Shigella, and co-
infection without EPEC, EHEC_O157, and STEC were
significantly associated with diarrhoea. However, after
controlling for confounders, only mono or co-infection
with EIEC/Shigella and wasting were determined to be
Table 4 Univariate and multivariate analysis of DEC mono-infection and co-infection associated with diarrhoeal disease among
children from 24 to 60 months of age using binary logistic regression model
Variable Univariate Model Multivariate Model
Odds Ratio 95% Confidence Interval P-valuec Odds Ratio 95% Confidence Interval P-valued
Types of infection a
Mono-infection with ETEC 0.39 0.15–1.05 0.062 0.32 0.11–0.94 0.037
Co-infection with ETEC 2.27 1.21–4.27 0.011
Co-infection without ETEC 1.74 1.00–3.02 0.051
Mono-infection with EAEC 0.51 0.28–0.93 0.028 0.45 0.24–0.86 0.015
Co-infection with EAEC 1.75 1.06–2.89 0.030
Co-infection without EAEC 2.55 1.19–5.46 0.016
Mono-infection with EIEC 52.13 12.57–216.21 < 0.001 49.66 11.90–207.24 < 0.001
Co-infection with EIEC 31.46 7.47–132.47 < 0.001 35.60 8.28–153.12 < 0.001
Co-infection without EIEC 0.66 0.37–1.20 0.173 0.63 0.34–1.18 0.149
Mono-infection with EPEC 0.55 0.32–0.95 0.031 0.59 0.34–1.02 0.057
Co-infection with EPEC 1.22 0.66–2.25 0.525
Co-infection without EPEC 2.97 1.65–5.34 < 0.001
Mono-infection with EHEC 0.90 0.33–2.44 0.834 0.96 0.35–2.64 0.937
Co-infection with EHEC 1.14 0.44–3.01 0.785
Co-infection without EHEC 2.19 1.36–3.52 0.001
Mono-infection with STEC –
Co-infection with STEC –
Co-infection without STEC 2.17 1.39–3.40 0.001
Gender
Female 0.81 0.61–1.07 0.142 0.65 0.47–0.91 0.013
Growth b
Obese 0.57 0.35–0.92 0.022 0.51 0.29–0.89 0.019
Overweight 0.88 0.57–1.36 0.560 1.00 0.62–1.62 0.998
Risk of overweight 0.68 0.46–1.01 0.053 0.83 0.54–1.27 0.390
Wasted 19.13 2.48–147.54 0.005 19.58 2.43–157.92 0.005
a Odds Ratio with the reference was non-infection status
b Odds Ratio with the reference was normal growth status
c P-value considered significant when p < 0.01
d P-value considered significant when p < 0.05
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significantly associated with diarrhoea. Conversely,
mono-infection with ETEC, EAEC, and obesity were sig-
nificantly more common in the non-diarrhoeal children.
Discussion
Here, we developed and applied an efficient and robust
collection of real-time PCR assays for identifying DEC in
MC sweeps isolated from stool samples from a
collection of healthy and diarrhoeal children. This ap-
proach, in comparison to the traditional method, is
straightforward, cost-effective and has a comparatively
short turn-around time [18]. Ultimately, the four multi-
plex real-time PCR assays could detect ten target se-
quences corresponding with six pathotypes of DEC,
which permitted detection of these pathogens with a
high degree of accuracy and utility. However, there are
some limitations with our approach. Due to their high
genetic similarity, we are unable to differentiate between
EIEC and Shigella spp. by using real-time PCR, as the in-
vasion plasmid antigen H (ipaH) and the uidA (the in-
ternal control gene for E. coli) are present in both [19].
Further limitations of this approach are associated with
issues of how pathotypes such as EPEC, EHEC, and
STEC are defined. Through bacterial genomics, we know
that organisms lacking either eae or stx or both may still
belong to the EHEC group [20, 21]. In addition, the stx
genes have been found in other pathotypes of E. coli [22,
23]. Therefore, it is impossible to definitively assign an
E. coli to a DEC pathotype without genome sequencing.
However, pathotyping DEC through detecting virulence
genes remains useful for assessing the potential preva-
lence of the various pathogenic forms of E. coli in any
given population. In addition to the methodological con-
straints of the study, as our control samples came from
healthy children over 12 months of age, we could not
evaluate associations with diarrhoea in children under 1
year of age and we recognise that co-infection with or-
ganisms that were not detected may impact on disease
presentation.
While ETEC is the most common DEC internationally,
the prevalence of ETEC in this setting was found to be
considerably lower than other regions [9, 18]. This result
is probably due to the study inclusion criteria, as only
children presenting with bloody and/or mucoid
diarrhoeal illness were enrolled, whereas ETEC is most
commonly associated with watery diarrhoea [7]. Here,
LT-ETEC were more prevalent than ST-ETEC, which is
consistent with earlier studies on ETEC infections in
children. However, in these previous studies the associ-
ation between LT-ETEC infection and diarrhoea was
weak [6, 9, 18]. In contrast, in the Global Enteric Multi-
centre Study (GEMS), ST-ETEC but not LT-ETEC was
attributed as a major cause of diarrhoea in all age groups
[24]. To determine whether ST-ETEC is an important
pathogen in Vietnam, it will be necessary to carry out
additional studies focusing on children presenting with
watery diarrhoea.
EAEC was the most commonly detected pathotype in
children with diarrhoea in this study, which is again con-
sistent with earlier studies that reported high detection
rates of EAEC compared to other DEC in Vietnam [16,
25]. Several articles have raised the possibility that not
all EAEC are pathogenic, and that variants within this
group may have different propensities to cause disease
[26–31]. However, several outbreaks and human volun-
teer studies have unequivocally shown that some EAEC
can cause disease [26–31]. Here, one third of EAEC
mono-infections required antimicrobial IV treatment
(i.e. the third generation cephalosporins or imipenem;
data not shown) associated with a more severe disease
presentation. Notably, samples from three children in
this study generated positive PCR amplicons for both
EAEC and stx. These cases may represent mixed
infections of EAEC and STEC, or potentially hybrid
organisms, such as those associated with an extensive
outbreak in Europe in 2011 [23]. Although EAEC was
not associated with diarrhoea in children within the 24–
60-month age group in this study, it was the most com-
monly detected pathotype from children with wasting.
This observation is consistent with the findings of the
recent the MAL-ED study, which reported that EAEC
infection is associated with growth shortfall, irrespective
of disease [32].
EPEC was the most common DEC gene target ampli-
fied from faecal samples of diarrhoea and non-diarrhoea
children. The overwhelming majority of the amplicons
generated from both healthy and diseased cohorts were
associated with aEPEC. These data are again consistent
with EPEC literature, which suggests that typical EPEC
is commonly identified in the African continent [18, 33],
while atypical EPEC tends to predominate in other re-
gions [34]. A case-control study conducted in seven
LMICs found that typical EPEC infections were signifi-
cantly associated with mortality in children under 5 years
[6]. The high prevalence of atypical EPEC positive sam-
ples in our study group (24–60 months of age) may be
partially associated with colonization in the first year of
life, as asymptomatic infection with ETEC, EAEC, and
EPEC have previously been associated with weaning and
the termination of breastfeeding [35].
STEC O157 cause severe diarrhoea and are associated
with a high mortality rate in food-borne outbreaks in
western countries [36]. EHEC_O157 in this setting had a
low prevalence and more than half the positive samples
were positive for the rfbE_O157 gene alone, which sug-
gests these are likely to be of lower pathogenicity. Only
two samples that tested positive for EHEC_O157 also
produced amplicons for the Shiga-toxin gene (stx2),
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suggesting that O157-STEC is not a significant cause of
gastrointestinal symptoms in this location. In the age
matched comparison, STEC were isolated from children
in the healthy group only. This observation is consistent
with data originating in Indonesia, where STEC was de-
tected significantly more frequently in non-diarrhoeal
children [37].
In previous studies, co-infection with more than one
DEC (or with other enteric pathogens) was found to be
significantly associated with diarrhoea [26, 38–41]. In
this study, we found that co-infection with DEC was not
associated with diarrhoea and was also common in
healthy children. Notably, only co-infection with EIEC/
Shigella was significantly associated with diarrhoeal dis-
ease. However, as EIEC/Shigella infection alone was
highly significantly associated with diarrhoeal illness, the
contribution of other DEC to disease in EIEC/Shigella
infection is unclear. In a multivariate logistic regression
model, DEC co-infection in the absence of EIEC/Shigella
was not associated with diarrhoea. This suggests that
EIEC/Shigella is the most important cause of DEC medi-
ated moderate-to-severe diarrhoea in this setting.
Conclusions
Multiplex real-time PCR is an efficient method for de-
tecting the six major pathotypes of DEC in a collection
of clinical samples. This new methodology provides a
useful alternative to classical microbiology for large-scale
microbiological and epidemiological studies. Using this
approach, we found a high prevalence of DEC in the
stools of both healthy and diarrhoeal children in
Vietnam. EAEC and atypical EPEC were the most com-
monly detected DEC in both groups; whereas, EIEC/Shi-
gella was the only DEC significantly associated with
diarrhoeal disease. This study provides new methodology
and baseline data for further clinical, epidemiological,
and genomic studies in Vietnam and across Southeast
Asia and shows that DEC are highly prevalent but not
generally associated with diarrhoeal disease in Vietnam.
Methods
Study design
Children aged ≤15 years with diarrhoeal illness admitted
to one of the three collaborating tertiary hospitals in
HCMC, Vietnam from May 2014 to April 2016 were eli-
gible for enrolment. Those with diarrhoeal illness (cases)
were defined as ≥3 passages of loose stools within 24-h
period along with at least one loose stool containing blood
and/or mucus [42]. We excluded children if they had sus-
pected or confirmed intussusception at the time of enrol-
ment [43]. Controls were healthy children between the
age of 12–60months enrolled in diarrhoeal disease cohort
in District 8 in HCMC from 2014 to 2016 [17]. The en-
rolled children attended HVH for routine health check
every six months. An anal swab of healthy child was col-
lected by study nurses at these routine visits.
Primer and probe design
The selected target genes for each pathotype were:
ETEC, eltB (heat-labile toxin) and/or estA (heat-stable
toxin); EAEC, aggR (transport regulator gene [44]); EIEC,
ipaH (secreted protein encoded on pINV [19]); EPEC,
eae (encoding the intimin adherence gene [7]) and bfpA
(encoding a structural component of the bundle forming
pilus [45]); STEC, stx1 and/or stx2 (Shiga toxins [7]);
and rfbE_O157 (encoding the lipopolysaccharide O157
antigen, the most common STEC serogroup in regions
where surveillance data is available). The uidA gene,
which encodes beta-glucuronidase and is present in all
E. coli, was used as an internal control to monitor both
DNA extraction and PCR amplification. A flowchart of
the combined assay strategy is shown in Fig. 1.
We classified the DEC amplification results using the
following approach; ETEC positive samples were divided
into LT-ETEC (eltB positive only); ST-ETEC (estA posi-
tive only); and LT-ST-ETEC (eltB and estA positive).
Amplification of aggR was sufficient for classification as
EAEC and a positive amplification for ipaH identified
EIEC/Shigella. EPEC positive samples were divided into
typical EPEC (carrying both eae and bfpA) and atypical
EPEC (the presence of eae only). The STEC pathotype
was identified by the presence of stx1 and/or stx2, and
the presence or absence of rfb_O157 was used to differ-
entiate between STEC O157 and the non-O157 STEC
serogroups. STEC that have the potential to cause HUS
carry additional virulence genes, specifically eae and
aggR.
The primer and probe sequences for aggR, ipaH, eae,
and uidA) were adapted from previous studies [46–49].
Reference sequences were downloaded from GenBank
eltB, estA (STh), bfpA, rfbE_O157, stx1 and stx2 (Table
S1) and aligned using AlignX (Vector NTI, Invitrogen)
to identify conserved regions within the gene sequence.
Primer Quest (IDT, USA) was employed to generate
primers and probes of amplicon size 100 to 150 bp. To
find optimal pairs, candidate primers and probes were
analysed for Tm, %GC, hairpin, self-dimer and hetero-
dimer using Oligo Analyzer 3.1 (http://sg.idtdna.com/
calc/analyzer). Final primer/probe candidates were
blasted against PrimerBLAST (https://www.ncbi.nlm.nih.
gov/tools/primer-blast/) to confirm the in-silico specifi-
city of the selected sequences. The selected primer and
probe sequences are shown in Table 5.
Isolation of nucleic acids and construction of control
plasmids
Nucleic acids were purified from prototypic E. coli
strains and a variety of other gastrointestinal pathogens
Duong et al. BMC Microbiology          (2020) 20:192 Page 7 of 12
using Wizard Genomic DNA Purification Kit (Pro-
mega). PCR amplicons were generated for each of
the 11 target genes and ligated into pCR™ 2.1-
TOPO® (Invitrogen, Applied Biosystem, UK). Purified
plasmids were used as template to optimize PCR re-
actions and measure assay reproducibility. Plasmid
concentrations (ng/μl) were quantified using a
Nanodrop spectrophotometer (Thermo-Scientific,
UK), and converted to copy number using the URI
Genomics and Sequencing Center online tool (http://
cels.uri.edu/gsc/cndna.html).
Real-time PCR
Multiplex real-time PCR reactions were performed in a
25 μl reaction mixture containing a final concentration
of 1X buffer, 0.2 mM deoxynucleoside triphosphates
(dNTPs), 3.5 mM of MgCl2, 0.2 μM of each forward and
reverse primers, 0.08 μM of each probe and 1 U of Hot-
start Taq polymerase (QIAGEN, Germany). Five μl of
DNA template was used for each PCR reaction. The
real-time PCR cycling conditions were as follows: 95 °C
for 15 min, followed by 45 cycles of 95 °C for 15 s, then
60 °C for 60s, using the Light Cycler 480 II system
Fig. 1 Multiplex PCR strategy. Flowchart showing the four multiplex real-time PCR assays for detecting target sequences of DEC; uidA (gene
encoded for β-glucuronidase and presented in all E. coli) was selected as an internal control
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(Roche, Germany). The threshold cycle (Ct) value for a
positive result was considered to be 38 or less.
Reproducibility and linearity analysis
The precision and reproducibility of the real-time PCR
assays were assessed using the co-efficient of variance
(CV%), measured by dividing the standard deviations of
the Ct values by the mean Ct values for each selected
concentration. The Ct values of three replicates assayed
simultaneously were compared to measure intra-assay
reproducibility. The inter-assay reproducibility was cal-
culated from data generated on three separate days. Lin-
earity was determined by linear regression, using Ct
values produced from 10-fold dilutions of control plas-
mid DNA.
Specimen culture and storage
Diarrhoeal faecal specimens were collected in sterile
containers and transported to the laboratory within 24 h
[43]. Anal swabs from non-diarrhoeal children were also
transported to the laboratory within 24 h for processing.
Specimens were inoculated onto MacConkey agar (MC,
Oxoid), and incubated at 37 °C for 18–24 h [43]. Follow-
ing incubation, a sweep of colonies was taken from the
entire MC agar plate and suspended in 20% glycerol in
Table 5 Sequences of primers and probes to detect DEC in this study
Diarrhoeagenic E. coli target Primer/probe name Sequence * (5′-3′) Amplicon size (bp)
ETEC elt_ETEC_F CTCGGTCAGATATGYGATTCTT 100
elt_ETEC_R AACATTTCAGGTCGAAGTCC
elt_ETEC_ probe FAM-TGTGTCCTTCATCCTTTC AATGGCTT-BHQ1
est_ETEC_F GCTAAACCAGYAGRGTCTTCAA 137
est_ETEC_R GCAGGATTACAACACAATTCAC
est_ETEC_ probe LCCyan500-AGTRGTCCTGAAA GCATGAATAGTAGCA-BHQ1
EAEC aggR_F CCATTTATCGCAATCAGATTAA 92 [46]
aggR_R CAAGCATCTACTTTTGATATTCC
aggR_probe FAM-CAGCGATACATTAAGA CGCCTAAAGGA-BHQ1
EIEC/Shigella ipaH_F AGGTCGCTGCATGGCTGGAA 99 [47]
ipaH_R CACGGTCCTCACAGCTCTCA
ipaH_probe LCCyan500-AACTCAGTGCCTCT GCGGAGCTTCGACA-BHQ1
EPEC/EHEC eae_F CATTGATCAGGATTTTTCTGGTGA TA 102 [48]
eae_R CTCATGCGGAAATAGCCGTTA
eae_probe FAM-ATAGTCTCGCCAGTA TTCGCCACCAATACC-BHQ1
EPEC bfpA_EPEC_ GTCTRTCTTTGATTGAATCKGC 108
bfpA_EPEC_R CATTCTGYGMCTTATTGGAATC
bfpA_EPEC_probe LCCyan500-ACCGTTACYGCM GGTGTGATGTTT-BHQ1
STEC stx1_EHEC_F GCATCTGATGAGTTTCCTTCTA 113
stx1_EHEC_R GTTCTGCGCATCAGAATTG
stx1_EHEC_probe FAM-AAGAGKCCGTGGGA TTACGCACAAT-BHQ1
stx2_EHEC_F ACRACGGACAGCAGYTATWC 111
stx2_EHEC_R GAACTCCATTAAMKCCAGATA
stx2_EHEC_probe LC Red 610-ATGCAAATCAGTCGTCA CTCACTGGT-BHQ1
EHE CO157 rfbE_O157_F CAAGTCCACAAGGAAAGTAAAG 111
rfbE_O157_R GAGTTTATCTGCAAGGTGATTC
rfbE_O157_probe LCCyan500-AACTCAGTGCCTCT GCGGAGCTTCGACA-BHQ1
Internal control uidA_F GTGTGATATCTACCCGCTTCGC 82 [49]
uidA_R AGAACGGTTTGTGGTTAATCAGGA
uidA_probe CY5-TCGGCATCCGGTCAGTGGCAGT-BHQ2
*R (A/G), Y(C/T), S (G/C), W (A/T), M (A/C), K (G/T) according to International Union of Pure and Applied Chemistry (IUPAC)
Probe detection format (Roche Light Cycler II 480) as followed FAM: 498–580; LCCyan500: 440–488; CY5: 618–660; LC Red 610: 533–610; BlackBerry® Quencher:
BHQ1, BHQ2
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Brain Heart Infusion (BHI) broth, before being stored at
− 80 °C.
Crude DNA extraction
Eighty μl of the stored colony sweep suspension was
centrifuged at 4000 rpm for 10 min, and the pellet was
resuspended in 80 μl of molecular grade water (Sigma).
The resulting suspension was mixed by gently pipetting
up and down, before being boiled at 96 °C for 10 min
and cooled to room temperature. The lysate was centri-
fuged at 4000 rpm for 10min to remove cellular debris,
and 5 μl of supernatant was subjected to the real-time
PCR assays.
Data collection and statistical analysis
Data were exported into Microsoft Excel (Microsoft,
USA), and analysed using Stata v11 (StataCorp, College
Station TX, USA). Descriptive comparisons between
groups were conducted using non-parametric tests in-
cluding χ2 test or Fisher’s exact test for categorical vari-
ables and the Kruskal-Wallis test for continuous data.
Growth status of participating patients were assessed
using the WHO global database on growth and nutrition
and Prevention and Management of Obesity for
Children and Adolescents-Healthcare guidelines using
the macro package of Stata v11 developed by WHO [50,
51]. Due to the age difference between diarrhoeal and
non-diarrhoeal groups, the comparative analyses were
performed between all the children in healthy group and
the subset children in the diarrhoea group that were
aged 24–60 months. Logistic regression was performed
to determine the associations with diarrhoea using each
type of infection considered as an independent variable.
Infections were classified as mono-infection of each
pathotype of DEC or co-infections of each specific
pathotype and other pathotypes. The types of co-infection
were repeated due to multi pathotype co-infection; hence
the p-value for univariate model was considered signifi-
cant when p < 0.01. Multivariable logistic regression
models were performed and incorporated mono-
infections, each specific type of co-infection, gender and
growth status with diarrhoea and non-diarrhoea as binary
outcomes (performed on Stata v11, StataCorp, College
Station TX, USA). For the latter, a p-value of < 0.05 was
considered significant. The figure for mixed-infections
(Fig. 2) was generated using the UpSetR package and
restructured manually to generate the side by side bar
graphs for comparing two groups [52].
Fig. 2 Mono- and co-infection with DEC in the 24–60-month-old healthy and diarrhoeal and healthy children. Bar chart demonstrating the
proportion of cases and controls with each combination of DEC pathotypes, with the most frequently isolated DEC pairings located near the
centre, the scale (y axis) in 5% increments. The dots and lines between dots at the base of the chart show the co-infection status for six
pathotypes of DEC. DEC co-infection patterns among diarrhoea group (N = 319; black) and healthy group (N = 498; grey)
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